Science

Restoring and supporting biological function.

Activome develops gene- and protein-restoration therapies with a single aim: to restore the biology that sustains human function, and that erodes with age.

Orientation

Function is the organizing principle.

Across the conditions we pursue — sarcopenia, neurodegenerative disease, and age-related decline — one mechanism recurs: the body's capacity to repair and renew its own tissue weakens over time. That decline is not simple wear. It reflects the fading of specific molecular signals that coordinate regeneration — and because those signals are specific and molecular, they are targets, not inevitabilities.

Activome's science begins there. We work to identify the regulators of regeneration whose loss drives functional decline, and to develop therapies designed to restore them. Our orientation is mechanism-first: a clear rationale, disciplined preclinical work, and a deliberate path to the clinic.

The approach

Restoration at the molecular level.

Rather than manage the downstream symptoms of decline, Activome develops therapies designed to restore the upstream regulators of regeneration themselves.

01 — Precise

Precise by design

Each program is directed at a specific molecular regulator whose decline is tied to loss of function — precision at the root, not the symptom.

02 — Restorative

Restorative intent

Our therapies are designed to restore what age takes away, reactivating the body's own regenerative machinery.

03 — Durable

Built for durability

We pursue durable, meaningful effect and long-term clinical relevance across related conditions.

Principles

How we hold ourselves to a standard.

Scientific rigor
Programs advance on the strength of evidence and mechanism, characterized with methodological discipline.
Translational focus
We build toward clinical relevance deliberately, respecting the distance between promising biology and durable clinical impact.
Responsible communication
We describe our work in investigational terms and do not claim safety or efficacy that has not been established.
A platform, not a single shot
The same restoration strategy is designed to generalize — extending to additional programs beyond the first as the science advances.

In development. The work described here is in active, early-stage development. Activome's programs have not been approved by any regulatory authority, and we make no claim of safety or efficacy that has not been established.